Evidence map›Paper›PMID 40862332›Full record

ReviewInternational journal of dermatology2026

Gonorrhea Management in High-, Limited- and No-Resource Settings: Implications in the Context of Antimicrobial Resistance.

Andrei Tanasov, Maciej Pastuszczak, George-Sorin Tiplica

Abstract readReview
In one paragraph

Review in International journal of dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Andrei TanasovCarol Davila University of Medicine and Pharmacy, Bucharest, Romania.ORCID https://orcid.org/0000-0002-7769-3234
Maciej PastuszczakDepartment of Dermatology, Medical University of Silesia, Katowice, Poland.ORCID https://orcid.org/0000-0001-7241-9685
George-Sorin TiplicaCarol Davila University of Medicine and Pharmacy, Bucharest, Romania.ORCID https://orcid.org/0000-0002-8719-6952

Funding

European Academy of Dermatology and Venereology PPRC-2024-0024
6 · The paper itself

Abstract

Gonorrhea, a common sexually transmitted infection caused by Neisseria gonorrhoeae, represents an escalating global public health threat due to antimicrobial resistance. The current review explores diverse approaches around the globe to gonorrhea management across various settings, with a focus on diagnostic strategies, treatment practices, resistance surveillance, and new trends, such as point-of-care tests or doxycycline post-exposure prophylaxis. High-resource settings benefit from proper infrastructure, advanced diagnostics, screening programs, surveillance, access to effective treatment, and test-of-cure protocols. Nonetheless, rising incidence and resistance rates persist. In contrast, limited-resource settings often depend on syndromic management, which lacks sensitivity and fails to identify asymptomatic infections. The low diagnostic capacity and poor access to resistance-guided therapy contribute to inappropriate antimicrobial use. Migrants, incarcerated individuals, and those in vulnerable contexts face additional barriers. These disparities undermine the global control efforts and enable the emergence of drug-resistant strains. Addressing these gaps requires a multifaceted, equity-focused approach: strengthening diagnostic capacity, expanding access to molecular testing and surveillance, tailored interventions for the local contexts, and promoting antibiotic stewardship in both policy and practice.

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialGonorrheaNeisseria gonorrhoeaeAntimicrobial StewardshipGlobal HealthHealth Services AccessibilityHumansPoint-of-Care TestingAnti-Bacterial Agentsantimicrobial resistancedoxycycline post‐exposure prophylaxisgonorrheahigh‐resource settingslow‐ and middle‐income countriesmigrant healthNeisseria gonorrhoeaepoint‐of‐care testingsexually transmitted infectionssyndromic management

Identifiers

PMID40862332
PMCPMC12892110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.